4//SEC Filing
Landau Jeffrey B 4
Accession 0001140361-23-012615
CIK 0001501989other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 6:43 PM ET
Size
6.0 KB
Accession
0001140361-23-012615
Insider Transaction Report
Form 4
Landau Jeffrey B
Chief Business Officer
Transactions
- Sale
Common Stock
2023-03-16$1.98/sh−1,477$2,923→ 69,248 total
Holdings
- 4,500(indirect: By IRA)
Common Stock
- 3,180(indirect: By IRA)
Common Stock
Footnotes (2)
- [F1]The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units.
- [F2]Includes 52,205 restricted stock units.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeother
Related Parties
1- filerCIK 0001918615
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 6:43 PM ET
- Size
- 6.0 KB